Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-01-05 Sale(A) |
2024-02-16 4:37 pm |
Athira Pharma Inc. | ATHA | Worthington Mark GENERAL COUNSEL |
2,412 | $2.91 | $7,019 | 34,452 (Direct) |
View |
| 2024-01-05 Sale(A) |
2024-02-16 4:34 pm |
Athira Pharma Inc. | ATHA | Gengos Andrew CFO AND CHIEF BUSINESS OFFICER |
1,208 | $2.91 | $3,515 | 83,804 (Direct) |
View |
| 2024-01-05 Sale(A) |
2024-02-16 4:32 pm |
Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER |
2,412 | $2.91 | $7,019 | 80,256 (Direct) |
View |
| 2023-01-05 Sale |
2024-01-08 4:42 pm |
Athira Pharma Inc. | ATHA | Gengos Andrew See Below |
1,208 | $2.91 | $3,515 | 83,804 (Direct) |
View |
| 2024-01-05 Sale |
2024-01-08 4:40 pm |
Athira Pharma Inc. | ATHA | Litton Mark James Chief Executive Officer |
4,820 | $2.91 | $14,026 | 164,086 (Indirect Direct) |
View |
| 2024-01-05 Sale |
2024-01-08 4:38 pm |
Athira Pharma Inc. | ATHA | Worthington Mark General Counsel |
2,412 | $2.91 | $7,019 | 34,452 (Direct) |
View |
| 2023-01-05 Sale |
2024-01-08 4:36 pm |
Athira Pharma Inc. | ATHA | CHURCH KEVIN Chief Scientific Officer |
2,412 | $2.91 | $7,019 | 80,256 (Direct) |
View |
| 2024-01-05 Sale |
2024-01-08 4:35 pm |
Athira Pharma Inc. | ATHA | Lenington Rachel Chief Operating Officer |
2,412 | $2.91 | $7,019 | 13,395 (Direct) |
View |
| 2023-12-27 Purchase |
2023-12-29 5:24 pm |
Athira Pharma Inc. | ATHA | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH Director 10% Owner |
605,686 | $2.4153 | $1,462,895 | 5,402,964 (Indirect) |
View |
| 2023-06-07 Purchase |
2023-06-09 5:06 pm |
Athira Pharma Inc. | ATHA | Gengos Andrew See Below |
15,000 | $3.4297 | $51,445 | 80,012 (Direct) |
View |
| 2023-06-02 Purchase |
2023-06-06 7:36 pm |
Athira Pharma Inc. | ATHA | Gengos Andrew See Below |
65,012 | $2.9467 | $191,572 | 65,012 (Direct) |
View |
| 2023-03-29 Purchase |
2023-03-31 4:36 pm |
Athira Pharma Inc. | ATHA | PICKERING GRANT Director |
25,000 | $2.414 | $60,350 | 25,783 (Direct) |
View |
| 2023-03-29 Purchase |
2023-03-30 6:59 pm |
Athira Pharma Inc. | ATHA | JOHNSON JAMES A Director |
5,000 | $2.4 | $12,000 | 5,000 (Direct) |
View |
| 2022-12-28 Purchase |
2022-12-30 4:58 pm |
Athira Pharma Inc. | ATHA | MILESON GLENNA Chief Financial Officer |
50,000 | $2.845 | $142,250 | 159,930 (Direct) |
View |
| 2022-12-02 Purchase |
2022-12-06 8:31 pm |
Athira Pharma Inc. | ATHA | Romano Kelly A Director |
30,000 | $3.29 | $98,700 | 38,315 (Direct) |
View |
| 2022-11-15 Purchase |
2022-11-17 7:10 pm |
Athira Pharma Inc. | ATHA | MOEBIUS HANS Chief Medical Officer |
5,000 | $3.2884 | $16,442 | 65,836 (Direct) |
View |
| 2022-06-29 Purchase |
2022-07-01 2:24 pm |
Athira Pharma Inc. | ATHA | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH Director 10% Owner |
1,371,362 | $2.99 | $4,100,372 | 4,797,278 (Indirect) |
View |
| 2022-06-28 Purchase |
2022-06-30 5:00 pm |
Athira Pharma Inc. | ATHA | MOEBIUS HANS Chief Medical Officer |
10,000 | $2.88 | $28,800 | 52,955 (Direct) |
View |
| 2022-06-23 Sale |
2022-06-24 7:55 pm |
Athira Pharma Inc. | ATHA | Worthington Mark General Counsel |
2,614 | $2.69 | $7,032 | 19,097 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-05-18 Option Award(A) |
2024-02-16 4:37 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Worthington Mark GENERAL COUNSEL |
7,767 | $2.41 | 34,452 (Direct) |
View |
| 2024-01-04 Option Award(A) |
2024-02-16 4:37 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Worthington Mark GENERAL COUNSEL |
10,000 | $0 | 34,452 (Direct) |
View |
| 2024-01-04 Option Award(A) |
2024-02-16 4:34 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Gengos Andrew CFO AND CHIEF BUSINESS OFFICER |
5,000 | $0 | 83,804 (Direct) |
View |
| 2023-11-20 Option Award(A) |
2024-02-16 4:32 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER |
3,397 | $1.34 | 80,256 (Direct) |
View |
| 2023-05-18 Option Award(A) |
2024-02-16 4:32 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER |
809 | $2.41 | 80,256 (Direct) |
View |
| 2024-01-04 Option Award(A) |
2024-02-16 4:32 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER |
10,000 | $0 | 80,256 (Direct) |
View |
| 2024-01-04 Option Award |
2024-01-08 4:45 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | MOEBIUS HANS Chief Medical Officer |
10,000 | $0 | 91,482 (Direct) |
View |
| 2023-01-04 Option Award |
2024-01-08 4:42 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Gengos Andrew See Below |
5,000 | $0 | 83,804 (Direct) |
View |
| 2024-01-04 Option Award |
2024-01-08 4:40 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Litton Mark James Chief Executive Officer |
20,000 | $0 | 164,086 (Direct) |
View |
| 2023-05-18 Option Award |
2024-01-08 4:38 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Worthington Mark General Counsel |
7,767 | $2.41 | 34,452 (Direct) |
View |
| 2024-01-04 Option Award |
2024-01-08 4:38 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Worthington Mark General Counsel |
10,000 | $0 | 34,452 (Direct) |
View |
| 2023-11-20 Option Award |
2024-01-08 4:36 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | CHURCH KEVIN Chief Scientific Officer |
3,397 | $1.34 | 80,256 (Direct) |
View |
| 2023-05-18 Option Award |
2024-01-08 4:36 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | CHURCH KEVIN Chief Scientific Officer |
809 | $2.41 | 80,256 (Direct) |
View |
| 2023-01-04 Option Award |
2024-01-08 4:36 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | CHURCH KEVIN Chief Scientific Officer |
10,000 | $0 | 80,256 (Direct) |
View |
| 2024-01-04 Option Award |
2024-01-08 4:35 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Lenington Rachel Chief Operating Officer |
10,000 | $0 | 13,395 (Direct) |
View |
| 2023-06-02 Exercise |
2023-06-06 7:35 pm |
N/A 2029-08-14 |
Athira Pharma Inc. | ATHA | MOEBIUS HANS Chief Medical Officer |
7,882 | $0 | 81,482 (Direct) |
View |
| 2023-06-02 Exercise |
2023-06-06 7:35 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | MOEBIUS HANS Chief Medical Officer |
7,882 | $1.35 | 81,482 (Direct) |
View |
| 2023-05-18 Option Award |
2023-06-06 7:35 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | MOEBIUS HANS Chief Medical Officer |
7,764 | $2.41 | 81,482 (Direct) |
View |
| 2023-05-19 Option Award |
2023-05-22 6:11 pm |
N/A 2033-05-18 |
Athira Pharma Inc. | ATHA | Romano Kelly A Director |
20,900 | $0 | 20,900 (Direct) |
View |
| 2023-05-19 Option Award |
2023-05-22 6:08 pm |
N/A 2033-05-18 |
Athira Pharma Inc. | ATHA | JOHNSON JAMES A Director |
20,900 | $0 | 20,900 (Direct) |
View |
| 2023-05-19 Option Award |
2023-05-22 6:06 pm |
N/A 2033-05-18 |
Athira Pharma Inc. | ATHA | Kosacz Barbara Director |
20,900 | $0 | 20,900 (Direct) |
View |
| 2023-05-19 Option Award |
2023-05-22 6:04 pm |
N/A 2033-05-18 |
Athira Pharma Inc. | ATHA | EDELMAN JOSEPH Director |
20,900 | $0 | 20,900 (Direct) |
View |
| 2023-05-19 Option Award |
2023-05-22 6:01 pm |
N/A 2033-05-18 |
Athira Pharma Inc. | ATHA | Panzara Michael A. Director |
20,900 | $0 | 20,900 (Direct) |
View |
| 2023-05-19 Option Award |
2023-05-22 5:58 pm |
N/A 2033-05-18 |
Athira Pharma Inc. | ATHA | FLUKE JOHN M JR Director |
20,900 | $0 | 20,900 (Direct) |
View |
| 2023-05-19 Option Award |
2023-05-22 5:56 pm |
N/A 2033-05-18 |
Athira Pharma Inc. | ATHA | PICKERING GRANT Director |
20,900 | $0 | 20,900 (Direct) |
View |
| 2023-05-18 Option Award |
2023-05-22 5:53 pm |
N/A 2033-05-17 |
Athira Pharma Inc. | ATHA | Gengos Andrew See Below |
400,000 | $0 | 400,000 (Direct) |
View |
Ownership |
2023-05-22 5:51 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Gengos Andrew See Below |
0 | $0 | 0 (Direct) |
View |
| 2023-03-24 Exercise |
2023-03-27 4:57 pm |
N/A 2028-12-17 |
Athira Pharma Inc. | ATHA | CHURCH KEVIN Chief Scientific Officer |
6,410 | $0 | 68,462 (Direct) |
View |
| 2023-03-24 Exercise |
2023-03-27 4:57 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | CHURCH KEVIN Chief Scientific Officer |
6,410 | $1.35 | 68,462 (Direct) |
View |
| 2022-11-18 Option Award |
2023-01-31 7:33 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Litton Mark James Chief Executive Officer |
662 | $2.74 | 573,906 (Direct) |
View |
| 2023-01-27 Option Award |
2023-01-31 7:33 pm |
N/A 2033-01-26 |
Athira Pharma Inc. | ATHA | Litton Mark James Chief Executive Officer |
425,000 | $0 | 573,906 (Direct) |
View |
| 2023-01-19 Option Award |
2023-01-23 5:55 pm |
N/A 2033-01-18 |
Athira Pharma Inc. | ATHA | Worthington Mark General Counsel |
150,000 | $0 | 150,000 (Direct) |
View |
| 2023-01-19 Option Award |
2023-01-23 5:53 pm |
N/A 2033-01-18 |
Athira Pharma Inc. | ATHA | MOEBIUS HANS Chief Medical Officer |
200,000 | $0 | 200,000 (Direct) |
View |
| 2023-01-19 Option Award |
2023-01-23 5:51 pm |
N/A 2033-01-18 |
Athira Pharma Inc. | ATHA | MILESON GLENNA Chief Financial Officer |
150,000 | $0 | 150,000 (Direct) |
View |
| 2023-01-19 Option Award |
2023-01-23 5:45 pm |
N/A 2033-01-18 |
Athira Pharma Inc. | ATHA | Lenington Rachel Chief Operating Officer |
200,000 | $0 | 200,000 (Direct) |
View |
| 2022-11-18 Option Award |
2023-01-23 5:26 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | CHURCH KEVIN Executive VP, Research |
657 | $2.74 | 212,052 (Direct) |
View |
| 2023-01-19 Option Award |
2023-01-23 5:26 pm |
N/A 2033-01-18 |
Athira Pharma Inc. | ATHA | CHURCH KEVIN Executive VP, Research |
150,000 | $0 | 212,052 (Direct) |
View |
| 2022-11-18 Option Award |
2022-12-30 4:58 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | MILESON GLENNA Chief Financial Officer |
763 | $2.74 | 159,930 (Direct) |
View |
| 2022-10-28 Exercise |
2022-10-31 8:17 pm |
N/A 2028-12-17 |
Athira Pharma Inc. | ATHA | CHURCH KEVIN Executive VP, Research |
3,700 | $0 | 67,805 (Direct) |
View |
| 2022-10-28 Exercise |
2022-10-31 8:17 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | CHURCH KEVIN Executive VP, Research |
3,700 | $1.35 | 67,805 (Direct) |
View |
| 2022-10-13 Exercise |
2022-10-17 6:06 pm |
N/A 2029-08-14 |
Athira Pharma Inc. | ATHA | MOEBIUS HANS Chief Medical Officer |
7,881 | $0 | 68,718 (Direct) |
View |
| 2022-10-13 Exercise |
2022-10-17 6:06 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | MOEBIUS HANS Chief Medical Officer |
7,881 | $1.35 | 68,718 (Direct) |
View |
| 2022-05-18 Option Award |
2022-06-24 7:55 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Worthington Mark General Counsel |
3,396 | $7.06 | 19,097 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 7:55 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Worthington Mark General Counsel |
10,000 | $0 | 19,097 (Direct) |
View |
| 2022-05-18 Option Award |
2022-06-24 7:54 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | MOEBIUS HANS Chief Medical Officer |
1,699 | $7.06 | 42,955 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 7:54 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | MOEBIUS HANS Chief Medical Officer |
10,000 | $0 | 42,955 (Direct) |
View |